MaxCyte, Inc. (MXCT)

NASDAQ: MXCT · USD

$1.71

+0.17 (+11.0%)· Recorded snapshot

Market cap	176.5M
Revenue (ttm)	31.1M
Net income (ttm)	-35.6M
EPS (ttm)	-$0.33
Shares out	103.2M
Volume	1,626,452
Beta	1.49

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 31.1M
Net income (ttm): -35.6M
EPS (ttm): -$0.33
Market cap: 176.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Conserver

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-20.4

P25 -113.8P50 -46.5P75 -0.9

ROIC-11.2

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All MXCT indicators

Market & fundamental data

Available fields

210

Groups with data

Currency

USD

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001287098
Company name	MaxCyte, Inc.
Country	United States
Country code	US
CUSIP number	57777K106
Earnings date	2026-11-10
Earnings time	amc
Employees	91
Employees change	-23
Employees growth	-20.18%
Enterprise value	$88M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1999
Industry	Medical Devices
IPO date	2021-07-30
Is primary listing	Yes
Is SPAC	No
ISIN number	US57777K1060
Last 10-K release date	2026-03-25
Last earnings date	2026-08-12
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$176.5M
Market cap category	Micro-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$1.71
Price currency	USD
Sector	Healthcare
SIC code	8731
Stock price date	2026-10-28
Symbol	MXCT
U.S. state	Maryland
Website	https://www.maxcyte.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-19.52%
EV/Sales	2.77x
FCF / EV yield	-27.5%
FCF yield	-13.55%
Forward EV/Sales	2.73x
Forward P/S	5.53x
Industry forward P/E	19.81x
Industry P/E	39.5x
P/B ratio	1.03x
P/S ratio	5.62x
Price / tangible book value	1.1x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-110.88%
EBITDA margin	-97.54%
Gross margin	79.23%
Operating margin	-110.88%
Pretax margin	-114.77%
Profit margin	-114.77%
Profit per employee	$-391,604
Revenue per employee	$341,220
ROA	-10.64%
ROA (5Y)	-9.76%
ROCE	-19.7%
ROE	-20.39%
ROE (5Y)	-15.99%
ROIC	-11.17%
SBC / revenue	15.98%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	3
EPS growth years	0
Gross profit growth	-13.77%
Gross profit growth (Q)	-19.92%
Gross profit growth 3Y	-11.42%
Gross profit growth 5Y	-0.92%
Net income growth quarters	3
Net income growth years	0
Revenue growth	-13.15%
Revenue growth (Q)	-14.53%
Revenue growth (QoQ)	-24.66%
Revenue growth 10Y	11.39%
Revenue growth 3Y	-8.61%
Revenue growth 5Y	1.46%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-665,000
Depreciation and amortization	$4.1M
EBIT	$-34.4M
EBITDA	$-30.3M
EPS	$-0.33
FCF per share	$-0.23
Financing cash flow	$-1.3M
Free cash flow	$-23.6M
Free cash flow minus SBC	$-28.6M
Gross profit	$24.6M
Investing cash flow	$24.1M
Net cash flow	$-183,000
Net income	$-35.6M
Operating cash flow minus SBC	$-27.9M
Operating income	$-34.4M
Revenue	$31.1M
Stock-based compensation	$5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.46
Book value per share	$1.50
Debt / equity	0.11
Long-term assets	$63.4M
Long-term liabilities	$16M
Net cash (debt)	$88.4M
Net cash / market cap	50.71%
Net cash growth	-18.15%
Net debt / equity	-0.56
Piotroski F-Score	2
Property, plant and equipment	$25.4M
Shareholders' equity	$158.8M
Tangible book value	$158M
Tangible book value per share	$1.49
Total assets	$184.7M
Total cash	$105.7M
Total debt	$17.3M
Total liabilities	$25.9M
WACC	11.33%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.15
Current assets	$121.3M
Current liabilities	$9.9M
Current ratio	12.26
Inventory turnover	0.82
Net working capital	$7.2M
Quick ratio	11.08
Working capital	$111.4M
Working capital turnover	0.26

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.95%
Dividend yield	0%
Shareholder yield	-0.95%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$1.12
1D price change	11.04%
1M price change	44.87%
1M total return	44.87%
1W price change	18.53%
1W total return	18.53%
1Y price change	10.07%
1Y return CAGR	10.07%
1Y total return	10.07%
20-day SMA	$1.25
200-day SMA	$1.06
3M price change	66.18%
3M total return	66.18%
3Y price change	-41.55%
3Y return CAGR	-16.39%
3Y total return	-41.55%
50-day SMA	$1.25
50-day SMA vs 200-day SMA	50over200
52-week high	$1.81
52-week high date	2025-11-19
52-week low	$0.64
52-week low date	2026-02-17
5Y price change	-83.96%
5Y return CAGR	-30.66%
5Y total return	-83.96%
6M price change	94.03%
6M total return	94.03%
All-time high	$17.44
All-time high date	2021-07-30
All-time low	$0.64
All-time low date	2026-02-17
Average true range (ATR)	$0.10
Average volume	1.5M
Beta (1Y)	1.3
Beta (2Y)	0.91
Beta (5Y)	1.49
Change from 52-week high	-5.26%
Change from 52-week low	165.78%
Change from all-time high	-90.28%
Change from all-time low	163.44%
Change from open	11.76%
Day's gap	-0.65%
Dollar volume	$2.8M
High price	$1.73
Low price	$1.53
Monthly RSI	43.33
Open price	$1.53
Position in 52-week range	92.31%
Premarket change	0%
Premarket close	$1.54
Premarket price	$1.54
Previous close	$1.54
Price vs 150-day SMA	51.34%
Price vs 20-day SMA	35.71%
Price vs 200-day SMA	60.06%
Price vs 50-day SMA	36.14%
Relative volume	1.1
Return from IPO open	-90.05%
Return from IPO price	-87%
RSI	77.78
Sharpe ratio	0.42
Sharpe ratio (3Y)	-0.01
Sharpe ratio (5Y)	-0.24
Sortino ratio	0.81
Sortino ratio (3Y)	0.07
Sortino ratio (5Y)	-0.27
Volume	1.6M
Weekly RSI	66
YTD price change	9.36%
YTD total return	9.36%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	93.7M
Float percentage	90.81%
Shares change (QoQ)	-0.05%
Shares change (YoY)	0.95%
Shares held by insiders	1.25%
Shares held by institutions	59.91%
Shares outstanding	103.2M
Short % of float	1.95%
Short % of shares	1.77%
Short ratio	1.8 days

Deeper analysis on MXCT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this MXCT report

Is a complete MXCT research report available?

No complete published report is available for MaxCyte, Inc. (MXCT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

MaxCyte, Inc. (MXCT)

Price

Financial snapshot

Fair-value bridge

Latest news · MXCT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MXCT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MXCT

Frequently asked questions